Celularity Share Price (NASDAQ: CELU)
$3.94
▲
0.09
(2.34%)
Last updated on
Check the interactive Celularity Stock chart to analyse performance
Celularity stock performance
as on August 30, 2025 at 1:29 am IST
- Today's Low:$3.75Today's High:$3.94
4.82%
Downside
Day's Volatility :4.82%
Upside
0.0%
- 52 Weeks Low:$1.0052 Weeks High:$5.22
74.6%
Downside
52 Weeks Volatility :80.83%
Upside
24.52%
Celularity Stock Returns
Celularity Inc Key Stats
Check Celularity key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Celularity Stock including INR - Dollar returns
The Celularity stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Celularity investment value today
Current value as on today
₹1,43,046
Returns
₹43,046
(+43.05%)
Returns from Celularity Stock
₹37,762 (+37.76%)
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Celularity Stock
Global Institutional Holdings in Celularity Inc
Name
Holdings %
C V Starr & Co Inc
3.19%
Vanguard Group Inc
2.09%
Geode Capital Management, LLC
0.57%
BlackRock Inc
0.42%
State Street Corp
0.27%
Royal Bank of Canada
0.25%
Analyst Recommendation on Celularity Stock
Buy
85%Buy
14%Hold
0%Sell
Based on 7 Wall street analysts offering stock ratings for Celularity(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Celularity Share Price Target
What analysts predicted
Downside of 36.55%
Target:
$2.50
Current:
$3.94
Celularity share price target is $2.50, a slight Downside of 36.55% compared to current price of $3.94 as per analysts' prediction.
Celularity Stock Insights
Price Movement
In the last 3 months, CELU stock has moved up by 85.3%Increasing Revenue
Revenue is up for the last 3 quarters, 9.29M → 18.13M (in $), with an average increase of 24.4% per quarterIncreasing Net Profit
Netprofit is up for the last 3 quarters, -16.09M → -13.29M (in $), with an average increase of 10.6% per quarterCELU vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 43.0%CELU vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 198.5%Price to Sales
ForCELU every $1 of sales, investors are willing to pay $1.6, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.
Celularity Inc Financials
Celularity Technicals Summary
Sell
Neutral
Buy
Celularity is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Celularity Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| 25.32% | 234.19% | 36.71% | -86.38% | -61.44% |
 | 6.48% | -15.2% | -50.31% | -3.3% | -2.01% |
 | 1.77% | 24.81% | 62.78% | 79.11% | 29.69% |
 | -14.45% | -19.13% | -17.84% | 34.68% | 41.87% |
 | 13.79% | 83.28% | 75.87% | 111.28% | 242.25% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| 2.28 | NA | NA | 0.0 | -2.33 | -0.17 | NA | 0.39 |
| 14.6 | 14.6 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.86 | 27.86 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $92.2M | -61.44% | 2.28 | -106.77% |
| Buy | $61.4B | -2.01% | 14.6 | 31.37% |
| NA | $36.5B | 29.69% | NA | -3.89% |
| Buy | $100.5B | 41.87% | 27.86 | 31.86% |
| Buy | $59.5B | 242.25% | NA | -12.96% |
About Celularity Inc
Key Management of Celularity Inc
Important FAQs about investing in CELU Stock from India :
What is Celularity share price today?
Celularity share price today is $3.94 as on at the close of the market. Celularity share today touched a day high of $3.94 and a low of $3.75.
What is the 52 week high and 52 week low for Celularity share?
Celularity share touched a 52 week high of $5.22 and a 52 week low of $1.00. Celularity stock price today i.e. is closed at $3.94, lower by 24.52% versus the 52 week high.
How to invest in Celularity Stock (CELU) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Celularity on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Celularity Shares that will get you 0.3807 shares as per Celularity share price of $3.94 per share as on August 30, 2025 at 1:29 am IST.
What is the minimum amount required to buy Celularity Stock (CELU) from India?
Indian investors can start investing in Celularity (CELU) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Celularity stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Celularity share’s latest price of $3.94 as on August 30, 2025 at 1:29 am IST, you will get 2.5381 shares of Celularity. Learn more about
fractional shares .
What are the returns that Celularity has given to Indian investors in the last 5 years?
Celularity stock has given -61.44% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
Cassava Sciences Inc$2.29
-3.78%
Collegium Pharmaceutical Inc$38.81
+1.2%
Axogen, Inc.$16.12
-0.62%
Rain Oncology Inc$3.84
-0.26%
- Scilex Holding Co
$17.84
-2.14%
Airsculpt Technologies$6.46
-3.0%
Mesoblast$13.81
-13.42%
Staar Surgical Co$27.33
-0.26%
Corbus Pharmaceuticals Holdings, Inc.$9.39
-5.15%